IGC Pharma, Inc. (IGC)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch IGC
See up to 3 months of IGC. The 7-day demo opens the 1M and 3M ranges and puts IGC on your watchlist.
Start 7-day demoLatest IGC insider trades
About IGC Pharma, Inc. (IGC)
IGC Pharma, Inc. is an SEC registrant, filing under CIK 0001326205, classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
IGC Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Bona-fide gift | 3 | 350,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
IGC insider transactions (Form 4)
3915 Form 4 filings on record, the earliest from Oct 20, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Ram Mukunda - Officer | Gift | Common Stock | 100,000 footnote F1 | $0.00 | - | |
| Ram Mukunda - Officer | Gift | Common Stock | 100,000 footnote F1 | $0.00 | - | |
| ||||||
| Claudia Grimaldi - Officer | Gift | Common Stock | 150,000 footnote F1 | $0.00 | - | |
| ||||||
| Ram Mukunda - Officer | Grant or award | Common Stock | 2,226,475 footnote F1 | $0.27 | $601K | |
| ||||||
| Claudia Grimaldi - Officer | Grant or award | Common Stock | 2,048,378 footnote F1 | $0.27 | $553K | |
| ||||||
| Richard K. Prins - Director | Option exercise | Common Stock | 100,000 footnote F1 | $0.00 | - | |
| Richard K. Prins - Director | Option exercise | Common Stock | 70,000 footnote F2 | $0.00 | - | |
| Richard K. Prins - Director | Option exercise | Restricted Stock Units | 100,000 footnote F1 | $0.00 | - | |
| Richard K. Prins - Director | Option exercise | Restricted Stock Units | 70,000 footnote F2 | $0.00 | - | |
| ||||||
| Ram Mukunda - Officer | Option exercise | Common Stock | 333,333 footnote F1 | $0.00 | - | |
| Ram Mukunda - Officer | Option exercise | Common Stock | 323,077 footnote F2 | $0.26 | $84K | |
| Ram Mukunda - Officer | Option exercise | Common Stock | 16,667 footnote F3 | $0.00 | - | |
| Ram Mukunda - Officer | Option exercise | Common Stock | 33,332 footnote F4 | $0.00 | - | |
| Ram Mukunda - Officer | Option exercise | Restricted Stock Units | 333,333 footnote F1 | $0.00 | - | |
| Ram Mukunda - Officer | Option exercise | Options | 323,077 footnote F2 | $0.00 | - | |
| Ram Mukunda - Officer | Option exercise | Restricted Stock Units | 16,667 footnote F3 | $0.00 | - | |
| Ram Mukunda - Officer | Option exercise | Restricted Stock Units | 33,332 footnote F4 | $0.00 | - | |
| ||||||
| James P. Moran - Director | Option exercise | Common Stock | 80,000 footnote F1 | $0.00 | - | |
| James P. Moran - Director | Option exercise | Common Stock | 50,000 footnote F2 | $0.00 | - | |
| James P. Moran - Director | Option exercise | Restricted Stock Units | 80,000 footnote F1 | $0.00 | - | |
| James P. Moran - Director | Option exercise | Restricted Stock Units | 50,000 footnote F2 | $0.00 | - | |
| ||||||
| Claudia Grimaldi - Officer | Option exercise | Common Stock | 100,000 footnote F1 | $0.00 | - | |
| Claudia Grimaldi - Officer | Option exercise | Common Stock | 138,462 footnote F1 | $0.26 | $36K | |
| Claudia Grimaldi - Officer | Option exercise | Restricted Stock Units | 100,000 footnote F1 | $0.00 | - | |
| Claudia Grimaldi - Officer | Option exercise | Options | 138,462 footnote F2 | $0.00 | - | |
| ||||||
| Ram Mukunda - Officer | Option exercise | Common Stock | 50,000 footnote F1 | $0.00 | - | |
| Ram Mukunda - Officer | Grant or award | Restricted Stock Units | 16,667 footnote F2 | $0.00 | - | |
| Ram Mukunda - Officer | Grant or award | Restricted Stock Units | 66,666 footnote F3 | $0.00 | - | |
| ||||||
| Richard K. Prins - Director | Option exercise | Common Stock | 100,000 footnote F1 | $0.00 | - | |
| Richard K. Prins - Director | Option exercise | Restricted Stock Units | 100,000 footnote F1 | $0.00 | - | |
| ||||||
| Richard K. Prins - Director | Grant or award | Options | 750,000 footnote F1 | $0.00 | - | |
| ||||||
| James P. Moran - Director | Grant or award | Options | 500,000 footnote F1 | $0.00 | - | |
| ||||||
| Terry L. Lierman - Director | Grant or award | Options | 500,000 footnote F1 | $0.00 | - | |
| ||||||
| Claudia Grimaldi - Officer | Grant or award | Options | 1,000,000 footnote F1 | $0.00 | - | |
| Claudia Grimaldi - Officer | Grant or award | Options | 500,000 footnote F2 | $0.00 | - | |
| Claudia Grimaldi - Officer | Gift | Common Stock | 50,000 footnote F3 | $0.00 | - | |
| ||||||
| Ram Mukunda - Officer | Grant or award | Options | 3,000,000 footnote F1 | $0.00 | - | |
| Ram Mukunda - Officer | Grant or award | Options | 1,500,000 footnote F2 | $0.00 | - | |
| Ram Mukunda - Officer | Gift | Common Stock | 100,000 footnote F3 | $0.00 | - | |
| ||||||
Item 7.01, 9.01
Item 1.01, 3.02, 9.01
Item 1.01, 2.03, 9.01
Item 1.01, 2.03, 3.02, 9.01
IGC insider trading FAQ
What is the latest insider trade for IGC?
IGC Pharma, Inc. (IGC) had 2 insider filings in the last 90 days, with the most recent on 2026-09-29. The full record for IGC runs to 15 Form 4 filings, the earliest from 2025-10-20. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying IGC stock?
No insider purchases of IGC were filed in the last 90 days.
How many insiders are selling IGC stock?
No insider sales of IGC were filed in the last 90 days.
Where can I see IGC SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects IGC Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Ram Mukunda view on EDGAR
- - Claudia Grimaldi view on EDGAR
- - Ram Mukunda view on EDGAR
- - Claudia Grimaldi view on EDGAR
- - Richard K. Prins view on EDGAR
- - Ram Mukunda view on EDGAR
- - James P. Moran view on EDGAR
- - Claudia Grimaldi view on EDGAR
- - Ram Mukunda view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where IGC's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow IGC with a 7-day demo
- IGC on your watchlist
- Every IGC Form 4 filing on record
- Up to 3 months of IGC price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
